IDPH: Office of Disease Control

Two years into the Covid-19 pandemic, testing remains critical to our pathway out of this crisis and return to normal. Rapid antigen tests are an effective public health tool to help us quickly identify positives and isolate and support those who need it. Increasingly, the constraints that have prevented their widespread use—including supply and price—are being addressed and overcome. One of the biggest challenges we face is and will be access: ensuring our most vulnerable and hard-to-reach citizens can access free tests. The price of a test or where someone lives should not prohibit access to an essential tool in our fight against a virus that continues to take the lives of nearly 2,000 Americans each day. To address this constraint, IDPH will issue a grant to The Rockefeller Foundation (RF) to implement Project Access Covid-19 tests (Project ACT) through its public charity, RF Catalytic Capital (RFCC). The goal of Project ACT is to help IL provide free Covid-19 rapid tests to households in vulnerable and hard-to-reach communities.

U.S. Department of Health and Human Services Centers for Disease Control and Prevention Statutory Authority 301 (A) and 317 (K) (2) PHS42USC241 (A) 247 B (K)2.

N/A

30 ILCS 708, TITLE 44: CHAPTER I: Section 7000

IDPH will provide a grant for supply of delivered tests, indicating the zip codes (based on Social Vulnerability Index (SVI) rankings) where residents will be able to requests tests.

Yes

N/A

Nonprofit Organizations;

Rockefeller Foundation Catalytic Capital, Inc.

Illinois residents

Project Grants

Public Safety

N/A

All grantees are required to register with the State of Illinois through the Grant Accountability and Transparency Act (GATA) website, www.grants.illinois.gov, complete a prequalification process, and be determined "qualified" as described in Section 7000.70. Registration and prequalification is required before an organization can apply for an award. The entity is "qualified" to be an awardee if it: 1) has an active UEI number; 2) has an active SAM.gov account; 3) has an acceptable fiscal condition; 4) is in good standing with the Illinois Secretary of State, if the Illinois Secretary of State requires the entity's organization type to be registered. Governmental entities, school districts and select religious organizations are not required to be registered with the Illinois Secretary of State. Refer to the Illinois Secretary of State Business Services website: http://www. cyberdriveillinois.com/departments/business_services/home.html; 5) is not on the Illinois Stop Payment List; 6) is not on the SAM.gov Exclusion List; 7) is not on the Sanctioned Party List maintained by HFS.

Applicants will utilize the IDPH EGRAMS database to submit their grant application. https://idphgrants.com/ Please utilize the instructional guide. https://idphgrants.com/misc/ViewTutorials.aspx#:~:text=EGrAMS%20Instructional%20Guide%20%E2%80%93%20Application%20Entry%20and%20Submission

The PROJECT Access to COVID 19 Tests (ACTs) -Phase II Testing 2023 grant is non-competitive. The named eligible applicant will receive an award. There are no merit-based review criteria for evaluating the application. The application will be reviewed for completeness and accuracy.

A Notice of State Award (NOSA) shall be issued to the finalists who have successfully completed all grant award requirements and have been selected to receive grant funding. The NOSA will specify the funding terms and specific conditions resulting from applicable pre-award risk assessments. The Illinois Department of Public Health (IDPH) is exempt from utilizing the standard NOSA issued on the GATA Grantee Portal. Successful applicants will receive an email notification from EGrAMS and must review the funding terms and specific conditions in the grant agreement and accept utilizing an electronically signature. Both the electronic signature in EGrAMS and a physical signature on the grant agreement must be completed by an authorized representative of the grantee organization and submitted to IDPH. A Notice of Denial shall be sent to the applicants not receiving awards via EGrAMS.

Application deadline is 09/15/2022

15-30 Days

Merit-Based Review Appeal Process For competitive grants, only the evaluation process is subject to appeal. Evaluation scores or funding determinations/outcomes may not be contested and will not be considered by the Department's Appeals Review Officer. To submit an appeal, the appealing party must: o Submit the appeal in writing and in accordance with the grant application document through IDPH's Merit-Based Review Appeal Request Form available in the following link https://app.smartsheet.com/b/form/ed4d113385de41feb38964a8005ce72b. Appeals must be received within 14 calendar days after the date that the grant award notice was published. Appeals must include the following information: The name and address of the appealing party, Identification of the grant, A statement of reasons for the appeal, If applicable, documents or exhibits to support statement of reason The IDPH Appeals Review Officer (ARO) will consider the grant-related appeals and make a recommendation to the appropriate Deputy Director as expeditiously as possible after receiving all relevant, requested information. The ARO must review the submitted Appeal Request Form for completeness and acknowledge receipt of the appeal within 14 calendar days from the date the appeal was received. o The ARO will utilize an Appeal Review Tool to consider the integrity of the competitive grant process and the impact of the recommendation. The appealing party must supply any additional information requested by the agency within the time period set in the request. The ARO shall respond to the appeal within 60 days or supply a written explanation to the appealing party as to why additional time is required..

N/A

N/A

All grant funds must be used for the sole purposes set forth in the grant proposal and application and must be used in compliance with all applicable laws. Grant funds may not be used as matching funds for any other grant program unless specifically allowed under grant program guidelines. Use of grant funds for prohibited purposes may result in loss of grant award and/or place the grantee at risk for repayment of those funds used for the prohibited purpose. Regardless of the source of funding (federal pass-through or State), all grant-funded expenses must be compliant with Cost Principles under Subpart E of 2CFR200 unless an exception is noted in federal or State statutes or regulations. Allowability Allowable – All grant funds must be used for items that are necessary and reasonable for the proper and efficient performance of the grant and may only be used for the purposes stated in the grant agreement, work plan, and budget. Items must comply with all applicable state and federal regulations. Allocable – Grant-funded costs must be chargeable or assignable to the grant in accordance with relative benefits received. The allocation methodology should be documented and should be consistent across funding sources for similar costs. Reasonable – The amounts charged for any item must be reasonable. That means the nature and amount of the expense does not exceed what a prudent person under the same circumstances would expend; and that the items are generally recognized as ordinary and necessary for the performance of the grant.

The grantee shall provide periodic financial and periodic performance reports in EGRAMS as directed.

Article XV Audit Requirements: Audits Grantee shall be subject to the audit requirements contained in the Single Audit Act Amendments of 1996 (31 USC 7501-7507) and Subpart F of 2 CFR Part 200, and the audit rules and policies set forth by the Governor’s Office of Management and Budget. See 30 ILCS 708/65(c); 44 Ill. Admin. Code 7000.90.

Grantee shall maintain for three (3) years from the date of submission of the final expenditure report, adequate books, all financial records and, supporting documents, statistical records, and all other records pertinent to this Award, adequate to comply with 2 CFR 200.333, unless a different retention period is specified in 2 CFR 200.333 or 44 Ill. Admin. Code §§ 7000.430(a) and (b).

063-48250-1900-0100

State Fiscal Year 2023: $6,230,000.00

N/A

PROJECT Access to COVID 19 Tests (ACTs) -Phase II Testing 2023 is a new program that has not yet experienced results or program accomplishments.

N/A

N/A

Springfield, Illinois.

https://idphgrants.com/user/home.aspx

N/A

N/A

9/2/2022

FY 2023 : $6,230,000